Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 3
- Exclusivities
- 2
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.
| Dosage form | NDCs |
|---|---|
| capsule | 2 |
| injection, powder, lyophilized, for solution | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| intravenous | 1 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| sentynl therapeutics, inc. | 4 |
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7504095 | NULIBRYfosdenopterin hydrobromide | product | Apr 2029 |
| 7838531 | ZOKINVYlonafarnib | use | Jul 2029 |
| Product | Exclusivity | Until |
|---|---|---|
| NULIBRYFOSDENOPTERIN HYDROBROMIDE | ODE-342 Orphan drug | Feb 2028 |
| ZOKINVYLONAFARNIB | ODE-324 Orphan drug | Nov 2027 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Nulibry | fosdenopterin hydrobromide | injection, powder, lyophilized, for solution, intravenous | 42358-295NDA |
| Zokinvy | lonafarnib | capsule, oral | 42358-450NDA |
| Zokinvy | lonafarnib | capsule, oral | 42358-475NDA |
| Zycubo | copper histidinate | injection, powder, lyophilized, for solution, subcutaneous | 42358-329NDA |
Compare
Other companies listing lonafarnib
- Lonza Bend Inc.0 sites · 4 NDC
Enquiry
Common questions
- Is Sentynl Therapeutics, Inc. FDA approved?
- Sentynl Therapeutics, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Sentynl Therapeutics, Inc. make?
- 4 products are listed under Sentynl Therapeutics, Inc. in the openFDA NDC Directory, most often as capsule; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.